Drugs / Doxazosine
last change Jun 2018 re-read 3 minutes ago

Doxazosine

Developed for
essential hypertension

Trials 0

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Comparator or background therapy1 trial
Phase 4 NCT00741585 Comparator Sep 2008 → Jun 2018 chronic kidney disease, essential hypertension, stroke disorder University of Vigo Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Doxazosine “Doxazosine” NCT00741585 ↗